{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:20:17Z","timestamp":1792020017037,"version":"4.4.0"},"reference-count":26,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T00:00:00Z","timestamp":1710028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health","award":["T32DK007745"],"award-info":[{"award-number":["T32DK007745"]}]},{"name":"Dedman Scholar in Clinical Care Award","award":["T32DK007745"],"award-info":[{"award-number":["T32DK007745"]}]},{"name":"Simmons Comprehensive Cancer Center Early Onset Colorectal Cancer Grant","award":["T32DK007745"],"award-info":[{"award-number":["T32DK007745"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Objectives: The effectiveness of colonoscopy to reduce colorectal cancer (CRC) mortality is extrapolated from cohort studies in the absence of randomized controlled trial (RCT) data, whereas flexible sigmoidoscopy is supported by RCT data and may be easier to implement in practice. We characterized the anatomic distribution of CRC to determine the proportion that is visible with sigmoidoscopy. Methods: Patients with a primary diagnosis of colorectal adenocarcinoma were identified in the Surveillance, Epidemiology, and End Results program (2000\u20132020). Tumors from the rectum to the descending colon were categorized as visible by sigmoidoscopy, whereas more proximal tumors required colonoscopy. Differential prognosis between tumor locations, stratified by age groups and stage, was assessed using the overall restricted mean survival time (RMST) at 2, 5, and 10 years. Results: Among 309,466 patients, 58% had tumors visible by sigmoidoscopy, including 73% of those under age 50 (OR 2.10, 95% CI 2.03\u20132.16 age &lt; 45, OR 2.20, 95% CI 2.13\u20132.27 age 45\u201349 versus age \u2265 50). Male sex (OR 1.54, 95% CI 1.51\u20131.56) and Asian or Pacific Islander race (OR 1.60, 95% CI 1.56\u20131.64) were also positively associated with tumors visualizable by sigmoidoscopy. Across age groups, for local disease, RMST was comparable for tumors visible versus not visible on sigmoidoscopy. For regional and metastatic cancer, patients with tumors visible by sigmoidoscopy had improved RMST versus those with more proximal tumors. Conclusions: 58% of CRC arises in locations visible by flexible sigmoidoscopy. Flexible sigmoidoscopy should be considered as a viable option for CRC screening, particularly in younger patients unwilling or unable to undergo colonoscopy.<\/jats:p>","DOI":"10.3390\/cancers16061110","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T04:51:12Z","timestamp":1710132672000},"page":"1110","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening Implications for Distribution of Colorectal Cancer Subsite by Age and Role of Flexible Sigmoidoscopy"],"prefix":"10.3390","volume":"16","author":[{"given":"Gloria","family":"Lin","sequence":"first","affiliation":[{"name":"Departments of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Hein","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina N.","family":"Sanford","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e2112593","DOI":"10.1001\/jamanetworkopen.2021.12593","article-title":"Colorectal Cancer Screening Starting at Age 45 Years-Ensuring Benefits Are Realized by All","volume":"4","author":"Mehta","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1158\/1055-9965.EPI-21-1330","article-title":"Persistent Disparities in Colorectal Cancer Screening: A Tell-Tale Sign for Implementing New Guidelines in Younger Adults","volume":"31","author":"Liu","year":"2022","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ajg.2017.174","article-title":"Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer","volume":"112","author":"Rex","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3748\/wjg.v25.i21.2565","article-title":"Colorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis","volume":"25","author":"Mannucci","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kingsley, J., Karanth, S., Revere, F.L., and Agrawal, D. (2016). Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates\u2014A Modeling Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167452"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106003","DOI":"10.1016\/j.ypmed.2020.106003","article-title":"Cost-utility of colorectal cancer screening at 40 years old for average-risk patients","volume":"133","author":"Azad","year":"2020","journal-title":"Prev. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3748\/wjg.v16.i4.425","article-title":"Colonoscopic perforation: Incidence, risk factors, management and outcome","volume":"16","author":"Lohsiriwat","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1300720","article-title":"Long-Term Mortality after Screening for Colorectal Cancer","volume":"369","author":"Shaukat","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2014.8266","article-title":"Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: A randomized clinical trial","volume":"312","author":"Holme","year":"2014","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/M17-0859","article-title":"Reanalysis of All-Cause Mortality in the U.S. Preventive Services Task Force 2016 Evidence Report on Colorectal Cancer Screening","volume":"167","author":"Swartz","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2208375","article-title":"Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death","volume":"387","author":"Bretthauer","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_12","unstructured":"(2023, April 19). SEER*Stat Database: Incidence-SEER Research Plus 17 Data Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute, DCCPS, Available online: www.seer.cancer.gov."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Royston, P., and Parmar, M.K. (2013). Restricted mean survival time: An alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. BMC Med. Res. Methodol., 13.","DOI":"10.1186\/1471-2288-13-152"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/sim.9681","article-title":"A comparison of different methods to adjust survival curves for confounders","volume":"42","author":"Denz","year":"2023","journal-title":"Stat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1002\/sim.8206","article-title":"Adjusted restricted mean survival times in observational studies","volume":"38","author":"Conner","year":"2019","journal-title":"Stat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0040-1713747","article-title":"Aggressive Colorectal Cancer in the Young","volume":"33","author":"Read","year":"2020","journal-title":"Clin. Colon Rectal Surg."},{"key":"ref_17","unstructured":"Surana, R., and Ng, K. (ASCO Post, 2022). The NordICC Trial: The Devil Is in the Details, ASCO Post."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archinternmed.2012.332","article-title":"Adherence to colorectal cancer screening: A randomized clinical trial of competing strategies","volume":"172","author":"Inadomi","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2021.5746","article-title":"Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force","volume":"325","author":"Knudsen","year":"2021","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1002\/cam4.3757","article-title":"The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis","volume":"10","author":"Azar","year":"2021","journal-title":"Cancer Med."},{"key":"ref_21","first-page":"2895","article-title":"Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45\u201349 Years vs Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines","volume":"20","author":"Ladabaum","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1001\/jama.2016.7914","article-title":"Blood-Based Screening for Colon Cancer: A Disruptive Innovation or Simply a Disruption?","volume":"315","author":"Parikh","year":"2016","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.2021.4417","article-title":"Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"325","author":"Lin","year":"2021","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e050698","DOI":"10.1136\/bmjopen-2021-050698","article-title":"Additional offer of sigmoidoscopy in colorectal cancer screening in Germany: Rationale and protocol of the decision-analytic modelling approach in the SIGMO study","volume":"12","author":"Diedrich","year":"2022","journal-title":"BMJ Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1503\/cjs.024320","article-title":"Patient and disease characteristics, treatment practices and oncologic outcomes among patients with colorectal cancer: A population-based analysis","volume":"66","author":"Farooq","year":"2023","journal-title":"Can. J. Surg. J. Can. Chir."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/ajg.2017.286","article-title":"Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design","volume":"112","author":"Dominitz","year":"2017","journal-title":"Am. J. Gastroenterol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/6\/1110\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:11:29Z","timestamp":1760105489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/6\/1110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,10]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["cancers16061110"],"URL":"https:\/\/doi.org\/10.3390\/cancers16061110","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,10]]}}}